Ostrava, Czechia

Ivan Mikes

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2022.


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ivan Mikes: Innovator in Biologically Available Curcumin Formulations

Introduction

Ivan Mikes is a notable inventor based in Ostrava Svinov, Czech Republic. He has made significant contributions to the field of biologically available curcumin formulations. His innovative work focuses on creating orodispersible tablets that enhance the bioavailability of curcumin, a compound known for its health benefits.

Latest Patents

Ivan Mikes holds a patent for a "Mixture of stabilized biologically available curcumin for orodispersible formulations." This patent includes formulations of biologically available curcumin and an orodispersible tablet containing curcumin. The orodispersible tablet is designed to contain particles of curcumin extract, which is grounded to a size of 100 to 250 nm. The formulation includes mannitol in a weight ratio of 1 to 3:1 (mannitol:curcumin) and ensures that curcumin is 100% biologically available through the oral mucosa.

Career Highlights

Throughout his career, Ivan Mikes has worked with various companies, including Imcopharma A.S. His innovative approach to curcumin formulations has positioned him as a key player in the field of nutraceuticals.

Collaborations

Ivan has collaborated with notable coworkers such as Jan Stonis and Andrea Dolezalova. Their combined expertise has contributed to the advancement of curcumin research and development.

Conclusion

Ivan Mikes is a pioneering inventor whose work in biologically available curcumin formulations has the potential to impact health and wellness significantly. His innovative patent and collaborations highlight his commitment to advancing this important field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…